Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Clarification or more confusion?
It appears Ken is saying that just because a license is announced doesn't mean the revenue from that signing will be recognized in the quarter of the announcement. It depends on when the company receives revenues, not when they are announced. Thus, it is reasonable to assume that much revenue from that quarter has yet to be realized.
Share
New Message
Please login to post a reply